ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its ...
PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the ...
Hepatocellular carcinoma (HCC) remains a primary cause of cancer-related mortality, particularly for individuals living with cirrhosis or chronic hepatitis B. While many expert associations recommend ...
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter, ...
Hepatic hypodensities are areas on the liver that appear darker on imaging tests like CT scans. They mean there is a difference in that area of tissue in the liver. These areas can be caused by a ...
GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results